Sorafenib in Combination with Intensive Chemotherapy for Previously Untreated Adult FLT3-ITD Positive AML: A Phase 2 Randomised Double-Blind Placebo Controlled Multi-Centre Study (ALLG AML M16)
Sorafenib in Combination with Intensive Chemotherapy for Previously Untreated Adult FLT3-ITD Positive AML: A Phase 2 Randomised Double-Blind Placebo Controlled Multi-Centre Study (ALLG AML M16)
Press Ctrl +⌘ + to increase font size.
Press Ctrl -⌘ - to decrease font size.
Press Ctrl 0⌘ 0 to reset font size.